Scienture LLC

Prioritizing Patients.

Improving Outcomes.

Scienture is focused on bridging gaps in patient treatment delivery systems to improve healthcare outcomes.

We work for a healthier world where the burden of disease is lightened through accessible, affordable, tailored therapies.

Who We Are
Grandmother hugging child.
Lab tech looking through a microscrope.

We discover and deliver selectively designed drug innovations that enhance the treatment experience. It all starts with the patient.

Our Science

Moving beyond traditional therapies, we aim to improve adherence journeys for patients whose needs have been overlooked.

Our Pipeline

Latest News

Press Releases

SCIENTURE announces manufacturing and supply chain readiness for Arbli™, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.

Learn More

Press Releases

Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days

Learn More

Press Releases

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.

Learn More

Press Releases

SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.

Learn More

Press Releases

Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics

Learn More

Press Releases

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041

Learn More

See all
Lab tech filling vials.

We invest in Delivering Better™

We are focused on identification and thoughtful selection of key access, commercialization, and support partners.

Investor Relations